PPE request

Ended Project Grant Awarded Last action

Award ID
S10AI174104
Recipient
Awarding agency
Obligated
$1,435,186

Award facts

Completion date
Place of performance
Washington, USA

Award details come from USAspending.gov.

Description

Abstract
On-going US government sponsored covid-19 vaccine trials require screening, enrolling, and following over 150,000 volunteer study participants over 24-36 months. The trial participants are selected based on their risk of covid-19 infection, with trial participants coming from settings with high rates of community transmission, groups with higher risk of progression to symptomatic disease, or both. Study staff working on covid-19 vaccine trials interact with trial participants during scheduled trial assessments and unscheduled sick visits, which includes high risk procedures such as nasal swabbing and performing physical examinations in often poorly ventilated environments. As a result, a regular supply of personal protective equipment (PPE), including surgical masks, face shields or goggles, gowns, and disposable gloves, is critical for their own protection and for prevention of transmission within the clinic. This project will provide on-going PPE support to covid-19 prevention network (covpn) trials across three continents, completing work anticipated through 2023. 1

Transactions

Action Obligated Date
Amendment -$3,545
Original award $1,438,731

Quick answers

Who received award S10AI174104?

S10AI174104 was awarded to Fred Hutchinson Cancer Center by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 2, 2023.

How much is award S10AI174104 worth?

$1,435,186 has been obligated on S10AI174104.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award